ArriVent Biopharma Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ArriVent Biopharma Inc
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team’s deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
/ 
Frequently asked questions
To buy ArriVent Biopharma Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ArriVent Biopharma Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ArriVent Biopharma Inc is AVBP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ArriVent Biopharma Inc has its primary listing on NASDAQ. You can trade ArriVent Biopharma Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ArriVent Biopharma Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ArriVent Biopharma Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ArriVent Biopharma Inc.